IL95574A - Colstiramine preparation - Google Patents

Colstiramine preparation

Info

Publication number
IL95574A
IL95574A IL9557490A IL9557490A IL95574A IL 95574 A IL95574 A IL 95574A IL 9557490 A IL9557490 A IL 9557490A IL 9557490 A IL9557490 A IL 9557490A IL 95574 A IL95574 A IL 95574A
Authority
IL
Israel
Prior art keywords
colestyramine
lipid
composition
lowering
preparation
Prior art date
Application number
IL9557490A
Other languages
English (en)
Hebrew (he)
Other versions
IL95574A0 (en
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19893930206 external-priority patent/DE3930206A1/de
Priority claimed from DE3930168A external-priority patent/DE3930168A1/de
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of IL95574A0 publication Critical patent/IL95574A0/xx
Publication of IL95574A publication Critical patent/IL95574A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Sealing Battery Cases Or Jackets (AREA)
  • Laminated Bodies (AREA)
IL9557490A 1989-09-09 1990-09-04 Colstiramine preparation IL95574A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19893930206 DE3930206A1 (de) 1989-09-09 1989-09-09 Pharmazeutische erzeugnisse
DE3930168A DE3930168A1 (de) 1989-09-09 1989-09-09 Verbesserte verabreichungsform fuer colestyramin

Publications (2)

Publication Number Publication Date
IL95574A0 IL95574A0 (en) 1991-06-30
IL95574A true IL95574A (en) 1994-11-11

Family

ID=25884990

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9557490A IL95574A (en) 1989-09-09 1990-09-04 Colstiramine preparation

Country Status (10)

Country Link
EP (1) EP0594570B1 (da)
JP (1) JPH05500213A (da)
KR (1) KR920703071A (da)
AT (1) ATE125448T1 (da)
AU (1) AU638493B2 (da)
CA (1) CA2065151A1 (da)
DE (1) DE59009451D1 (da)
DK (1) DK0594570T3 (da)
IL (1) IL95574A (da)
WO (1) WO1991003249A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011326871B2 (en) 2010-11-08 2015-02-12 Albireo Ab IBAT inhibitors for the treatment of liver diseases
JP6751020B2 (ja) 2014-06-25 2020-09-02 Ｅａファーマ株式会社 固形製剤及びその着色防止又は着色低減方法
EP3012252A1 (en) 2014-10-24 2016-04-27 Ferring BV Crystal modifications of elobixibat
WO2017138877A1 (en) * 2016-02-09 2017-08-17 Albireo Ab Oral cholestyramine formulation and use thereof
CN108601745B (zh) * 2016-02-09 2021-12-07 阿尔比里奥公司 口服考来烯胺制剂及其用途
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
CA3011595C (en) * 2016-02-09 2024-01-02 Albireo Ab Cholestyramine pellets and methods for preparation thereof
CA3071182A1 (en) * 2017-08-09 2019-02-14 Albireo Ab Cholestyramine pellets, oral cholestyramine formulations and use thereof
CN111032019B (zh) 2017-08-09 2022-07-05 阿尔比里奥公司 考来烯胺颗粒、口服考来烯胺制剂及其用途
ES2942443T3 (es) 2018-06-05 2023-06-01 Albireo Ab Compuestos de benzotia(di)azepina y su uso como moduladores de ácidos biliares
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
TWI823954B (zh) 2018-06-20 2023-12-01 瑞典商艾爾比瑞歐公司 奧德維希百(odevixibat)之結晶修飾物
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
JP2023504647A (ja) 2019-12-04 2023-02-06 アルビレオ・アクチボラグ ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
MX2022006731A (es) 2019-12-04 2022-06-09 Albireo Ab Compuestos de benzoti(di)azepina y su uso como moduladores del acido biliar.
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
JP2023504643A (ja) 2019-12-04 2023-02-06 アルビレオ・アクチボラグ ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
JP2023504644A (ja) 2019-12-04 2023-02-06 アルビレオ・アクチボラグ ベンゾチアジアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
CN116157389A (zh) 2020-08-03 2023-05-23 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
KR20230106651A (ko) 2020-11-12 2023-07-13 알비레오 에이비 진행성 가족성 간내 담즙정체증(pfic)을 치료하기 위한 오데빅시바트
CA3198216A1 (en) 2020-12-04 2022-06-09 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1348642A (en) * 1970-10-15 1974-03-20 Howard A N Hypocholesterolaemic compositions
GB1566609A (en) 1977-03-10 1980-05-08 Reckitt & Colmann Prod Ltd Pharmaceutical compositions containing cholestyramine and alginic acid
EP0166315B1 (de) 1984-06-19 1989-08-23 BASF Aktiengesellschaft Magensaftresistent überzogene zylindrische Pankreatin-Mikrotabletten
ZA876640B (en) 1986-09-26 1988-03-08 Warner-Lambert Company Treated lipid regulator
US4814354A (en) 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
CA1313135C (en) * 1987-02-09 1993-01-26 The Dow Chemical Company Cholestyramine composition and process for its preparation
DE3869590D1 (de) * 1987-12-29 1992-04-30 Procter & Gamble Mischung zur behandlung von hypercholesterolemie.
DE3808191C2 (de) 1988-03-11 1998-08-06 Astra Chem Gmbh Colestyramin enthaltende pharmazeutische Zusammensetzung
US4931280A (en) 1988-06-13 1990-06-05 Basf K & F Corporation Edible, baked compositions containing cholestyramine

Also Published As

Publication number Publication date
DE59009451D1 (de) 1995-08-31
EP0594570A1 (de) 1994-05-04
AU6405790A (en) 1991-04-08
KR920703071A (ko) 1992-12-17
CA2065151A1 (en) 1991-03-10
WO1991003249A1 (de) 1991-03-21
IL95574A0 (en) 1991-06-30
EP0594570B1 (de) 1995-07-26
AU638493B2 (en) 1993-07-01
ATE125448T1 (de) 1995-08-15
DK0594570T3 (da) 1995-09-11
JPH05500213A (ja) 1993-01-21

Similar Documents

Publication Publication Date Title
IL95574A (en) Colstiramine preparation
US5478578A (en) Powders for inhalation
RU2003126257A (ru) Твердая дозированная лекарственная форма для орального введения, содержащая комбинацию метформина и глибенкламида
CA2406373C (en) Controlled release paracetamol composition
UA29513C2 (uk) Фармацевтична композиція, що включає (е)-3,5-дигідрокси-7-[4'-4''-фторфеніл-2'-циклопропілхінолін-3'-іл]-6- гептенову кислоту
UA75047C2 (en) Fixed dose composition of levodopa, carbidopa and entacapone
GB2137496A (en) Use of fluoxetine as an anti-anxiety agent
EP0011490B1 (en) Analgesic tablet and process for its preparation
EP0181650A1 (en) Compression-coated dispersible tablets
EP0689434B1 (en) Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof
KR20040100835A (ko) 안정된 제약및 갑상선 내분비 호르몬 구성물 및 그제조방법
EP0414688B1 (en) Process for regulating the absorption rate of drugs and a pharmaceutical formulation
US3873709A (en) Method of treating psychosis
CN107811983A (zh) 一种托格列净组合物
JP2000229853A (ja) 生理痛改善用組成物
KR830008678A (ko) 진통 조성물
RU2174836C1 (ru) Фармацевтическая композиция, обладающая анальгезирующим действием
JPH06227995A (ja) 安定化された固型製剤
US3478151A (en) Compositions of perphenazine and protriptyline for treating mental disorders
US2793157A (en) Anticonvulsant 3-ethyl-5-phenyl hydantoin unit dosages and method of using same
JPS6360926A (ja) 感冒薬
RU2200556C1 (ru) Лекарственная форма налтрексона
JPH07188040A (ja) 鼻炎治療用組成物
JPH06239744A (ja) 感冒薬
KR900701284A (ko) 미분된 콜레스티폴 하이드로클로라이드

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees